NanoSphere Health Sciences Inc.
NSHS
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.54% | 83.74% | -123.86% | 1,076.98% | 31.75% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -139.11% | -132.31% | 110.13% | -2,906.04% | -241.09% |
| Change in Net Operating Assets | -121.17% | -39.76% | -25.36% | 892.06% | -81.05% |
| Cash from Operations | -390.22% | -56.31% | 450.34% | 68.99% | -359.02% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -107.58% | 266.67% | 280.00% | -106.49% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -107.58% | 266.67% | 280.00% | -106.49% | -- |
| Foreign Exchange rate Adjustments | 293.13% | 39.42% | -890.00% | 22.81% | 254.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.57% | 1,250.00% | 97.96% | 10.09% | -174.66% |